Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up

被引:166
作者
Dimaraki, EV
Jaffe, CA
DeMott-Friberg, R
Chandler, WF
Barkan, AL
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Endocrinol & Metab, Dept Neurosurg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Pituitary & Neuroendocrine Ctr, Ann Arbor, MI 48109 USA
[4] Vet Affairs Med Ctr, Ann Arbor, MI 48109 USA
关键词
D O I
10.1210/jc.87.8.3537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biochemical diagnosis of acromegaly is conventionally based on elevated plasma GH levels that fail to suppress after an oral glucose load. We studied 16 newly diagnosed patients with acromegaly with normal mean plasma GH but elevated age and gender-adjusted plasma IGF-I concentrations (476 +/- 29 mug/liter, mean SE). Plasma GH was sampled every 10 min for 24 h, and an oral glucose tolerance test was performed. The control group included 46 healthy subjects. All patients had 24-h mean GH values that overlapped with those of the healthy controls. Mean plasma GH was less than 2.5 mug/liter in 12 patients. Patients had higher 24-h nadir GH values than healthy controls (P < 0.001). During the oral glucose tolerance test, nadir plasma GH was less than 1 mug/liter in eight patients. Plasma IGF-I normalized in 11 of 14 patients after transsphenoidal surgery. Four patients with normal IGF-I after transsphenoidal surgery were restudied. Mean and nadir GH decreased in all of them. In our experience in many patients with acromegaly, the diagnosis could be missed if only the existing GH-based criteria are used. Revised GH criteria in combination with plasma IGF-I should be used for the diagnosis and follow-up of acromegaly.
引用
收藏
页码:3537 / 3542
页数:6
相关论文
共 27 条
  • [1] DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY
    BATES, AS
    VANTHOFF, W
    JONES, JM
    CLAYTON, RN
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01): : 1 - 5
  • [2] BATES AS, 1993, Q J MED, V86, P293
  • [3] NEGATIVE FEEDBACK-REGULATION OF PULSATILE GROWTH-HORMONE SECRETION BY INSULIN-LIKE GROWTH-FACTOR-I - INVOLVEMENT OF HYPOTHALAMIC SOMATOSTATIN
    BERMANN, M
    JAFFE, CA
    TSAI, W
    DEMOTTFRIBERG, R
    BARKAN, AL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) : 138 - 145
  • [4] ACROMEGALY WITH NORMAL SERUM GROWTH-HORMONE LEVELS - CLINICAL-FEATURES, DIAGNOSIS AND RESULTS OF TRANSSPHENOIDAL MICROSURGERY
    BROCKMEIER, SJ
    BUCHFELDER, M
    ADAMS, EF
    SCHOTT, W
    FAHLBUSCH, R
    [J]. HORMONE AND METABOLIC RESEARCH, 1992, 24 (08) : 392 - 396
  • [5] CHOOSING THE BEST TREATMENT FOR ACROMEGALY
    CHRISTY, NP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (09): : 1320 - 1320
  • [6] EVALUATION OF ACROMEGALY BY RADIOIMMUNOASSAY OF SOMATOMEDIN-C
    CLEMMONS, DR
    VANWYK, JJ
    RIDGWAY, EC
    KLIMAN, B
    KJELLBERG, RN
    UNDERWOOD, LE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (21) : 1138 - 1142
  • [7] CHARACTERIZATION OF SERUM GROWTH-HORMONE (GH) AND INSULIN-LIKE GROWTH FACTOR-I IN ACTIVE ACROMEGALY WITH MINIMAL ELEVATION OF SERUM GH
    DAUGHADAY, WH
    STARKEY, RH
    SALTMAN, S
    GAVIN, JR
    MILLSDUNLAP, B
    HEATHMONNIG, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (04) : 617 - 623
  • [8] NEW CRITERIA FOR EVALUATION OF ACROMEGALY
    DAUGHADAY, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (21) : 1175 - 1176
  • [9] Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly
    Freda, PU
    Post, KD
    Powell, JS
    Wardlaw, SL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11) : 3808 - 3816
  • [10] Criteria for cure of acromegaly: A consensus statement
    Giustina, A
    Barkan, A
    Casanueva, FF
    Cavagnini, F
    Frohman, L
    Ho, K
    Veldhuis, J
    Wass, J
    Von Werder, K
    Melmed, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) : 526 - 529